How to Switch From Compounded Semaglutide to Tirzepatide

Should You Actually Switch? An Honest Decision Filter

Before we get into the how, let’s talk about whether you should. Switching medications is not a casual decision, and not everyone on compounded semaglutide needs to make this move.

Consider switching if:

• ✓You've been at an adequate semaglutide dose for months and progress has clearly stalled. If you've maxed out your tolerated dose and the scale hasn't moved despite consistent habits — tirzepatide's dual GLP-1 + GIP mechanism may break through where semaglutide alone can't.
• ✓Your compounded semaglutide access is ending or becoming unreliable. This is the most common trigger behind this search right now.
• ✓Semaglutide side effects are interfering with daily life. And aren't improving despite dose adjustments and management strategies.
• ✓Your blood sugar control needs aren't being fully met on semaglutide alone. Tirzepatide's dual-receptor action has shown stronger glycemic control in clinical trials.

Stay on semaglutide if:

• →You're still actively losing weight. If semaglutide is working, there is no clinical reason to switch just because tirzepatide averages higher in studies. Averages aren't guarantees.
• →Budget is your primary concern. FDA-approved tirzepatide costs $299–$449/month self-pay.¹ If your current medication is significantly cheaper and still working, switching purely for marginal improvement may not justify the cost increase.
• →You had limited response to semaglutide at adequate doses. Some people have a limited response to incretin-based medications overall. If you saw minimal results even at adequate doses, tirzepatide may offer some improvement — but set realistic expectations.

Why People Are Suddenly Having to Switch Off Compounded Semaglutide

If you’re reading this, you already know something changed. Here’s what happened and why it matters for your next step.

The regulatory shift

The FDA declared the semaglutide injection shortage resolved on February 21, 2025, and the tirzepatide injection shortage resolved on December 19, 2024.⁴ Those two dates changed everything.

While the drugs were on the shortage list, compounding pharmacies operated under a legal pathway (Section 503A/503B of the Federal Food, Drug, and Cosmetic Act) that allowed them to produce copies. Once shortages were declared resolved, that pathway narrowed significantly.

How Tirzepatide Works Differently Than Semaglutide — And Why Switching Often Breaks a Plateau

Understanding the mechanism difference explains why switching often works — and when it won’t.

What the head-to-head data shows

The strongest evidence comes from the SURMOUNT-5 trial — the first large head-to-head study comparing tirzepatide and semaglutide specifically for weight loss in adults with obesity (without diabetes), published in the New England Journal of Medicine:⁶

A separate matched real-world cohort study of 18,386 patients found tirzepatide users were more likely to achieve 5%, 10%, and 15% weight-loss thresholds and had greater adjusted weight loss at 3, 6, and 12 months.⁷

The 4-Step Switching Protocol Most Clinicians Use

Here’s the actual process. It’s more straightforward than most people expect.

Do You Need a Washout Period Between Semaglutide and Tirzepatide?

Usually, no. Semaglutide’s half-life is approximately 7 days.⁹ After your last injection, the drug level naturally declines. By the time your next injection day arrives — roughly one week later — you’re at a natural transition point. That’s why most clinicians don’t require a separate washout period.

Some providers may suggest waiting 10–14 days if you experienced severe GI side effects on semaglutide, are coming off a very high compounded dose, or have specific health conditions that warrant extra caution. For most people, though: last semaglutide dose → wait one week → first tirzepatide dose.

Is There a Semaglutide-to-Tirzepatide Conversion Chart?

There is no validated, official dose-equivalence chart between semaglutide and tirzepatide — not from the FDA, not from Eli Lilly, not from Novo Nordisk. Any website publishing a confident mg-to-mg crosswalk is offering false precision in a space where it doesn’t exist.

• ✗They work through different receptor pathways. Semaglutide is GLP-1 only. Tirzepatide is dual GLP-1/GIP. The milligram numbers are not interchangeable.
• ✗Compounded vials make this worse. Compounded semaglutide comes in varying concentrations. One vial might be 1 mg/mL, another 5 mg/mL. The dose you've been taking in 'units' could mean very different actual milligrams depending on concentration.
• ✗FDA has documented the danger. The FDA issued a specific alert about dosing errors with compounded semaglutide, including cases where patients took many times the intended dose due to confusion around units, concentrations, and self-measurement.¹⁰

What If Your Compounded Semaglutide Was Labeled in Units, mL, or Mixed With B12?

This is the gap that generic switching guides don’t address — and it’s the reality for many people on compounded semaglutide.

The units problem

Many compounding pharmacies instructed patients to dose in “units” on an insulin syringe rather than milligrams. “30 units” on an insulin syringe means 0.3 mL of liquid. If your vial is 2.5 mg/mL, that’s 0.75 mg. If your vial is 5 mg/mL, that’s 1.5 mg — double the dose from the same “30 units.” This is exactly the kind of confusion that has led to serious dosing errors and hospitalizations.¹⁰

What your vial label should show

• •Drug name: Semaglutide (possibly with additives like B12 or L-carnitine)
• •Concentration: Listed as mg/mL (e.g., '2.5 mg/mL' or '5 mg/mL')
• •Total volume: How many mL are in the vial
• •Pharmacy name and contact info
• •Beyond-use date (expiration)

What about B12 and other additives? These don’t change your semaglutide dose, but they’re worth mentioning to your prescriber — they confirm you were on a compounded product, and some additives can affect injection site reactions.

What to Bring to Your Prescriber Before You Switch

This section is your action engine. Everything above gave you knowledge. This gives you what to do with it.

What to Expect During the Transition

The first month on tirzepatide is primarily an initiation period. Because you’re beginning at 2.5 mg regardless of your previous semaglutide dose, the first few weeks may feel like a step back — particularly if you were on a high dose. Appetite suppression may be less noticeable than what you’re used to. That’s normal at a starter dose, and it builds as you titrate up.

GI side effects — nausea, diarrhea, constipation, abdominal discomfort — are common during initiation. The Zepbound label notes these generally decreased over time.³ Many people who’ve been on semaglutide report the adjustment feels milder than when they first started GLP-1 therapy — though individual experiences vary.

As you reach higher therapeutic doses (typically 7.5 mg and above), the dual GLP-1/GIP mechanism is more fully engaged. This is when most people begin to see meaningful differences in appetite control and weight trajectory compared to their semaglutide experience.

What might not go as planned

• →If you had limited response to semaglutide at adequate doses, tirzepatide may offer some improvement — but likely won’t transform your results.
• →Muscle loss is a risk with both medications. Resistance training and adequate protein (at least 0.7–1.0 g/lb body weight daily) are essential.
• →Psychological eating patterns don’t always change. These medications reduce physical hunger, but stress eating and ingrained habits can persist.

Side Effects: What Changes When You Switch

The side effect profile is similar to what you experienced starting semaglutide. The Zepbound label lists these as common: nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection site reactions, fatigue, belching, hair loss, and heartburn.³

Practical management tips

• •Eat smaller, more frequent meals during the first 2–4 weeks
• •Stay aggressively hydrated — aim for 80+ oz of water daily
• •Take your injection in the evening if nausea is bothersome
• •Avoid high-fat and high-sugar meals, which tend to worsen GI symptoms

How Much Does Switching to Tirzepatide Cost in 2026?

Let’s be direct about the money. For many people, switching means paying more than they were on compounded semaglutide.

Zepbound self-pay pricing through LillyDirect

*Journey Program price requires refilling within 45 days of previous delivery. Prices verified April 2026 via zepbound.lilly.com/savings.¹

How to minimize costs

• 1.Check insurance first. Call the number on the back of your card and ask specifically about tirzepatide (Zepbound) coverage for weight management. Some plans that denied semaglutide do cover tirzepatide.
• 2.Use the Zepbound savings card at zepbound.lilly.com/savings for eligible commercially insured patients.²
• 3.Ask about the OSA indication if you have documented sleep apnea and obesity — separate coverage pathway for some plans.
• 4.Consider LillyDirect first if you already have a prescriber — cutting out a telehealth membership fee saves money.
• 5.HSA/FSA reimbursement may be available, though coverage rules vary. Check with your plan administrator before assuming eligibility.

Which Access Path Is Best for You?

Not everyone should take the same route. Here’s how to think through it.

Will You Regain Weight During the Switch?

A short, planned transition usually does not mean starting over — especially because semaglutide has a long half-life of about one week.⁹ The 7-day gap between your last semaglutide injection and your first tirzepatide dose keeps you within that pharmacological window.

You may see a small fluctuation in the first few weeks from water retention changes and food volume shifts as the starter dose provides less appetite suppression than your previous sema dose. This is not the same as fat regain.

What You Should NOT Do During the Switch

These are the specific mistakes that send people back to searching for help.

Is Compounded Tirzepatide Still Available — and Should You Use It?

Compounded tirzepatide is still available through some pharmacies and telehealth platforms. But the landscape has changed significantly:

• •FDA declared the tirzepatide shortage resolved on December 19, 2024⁴
• •The legal pathway for routine compounding narrowed significantly
• •FDA issued warning letters to 30+ telehealth companies in early 2026 for misleading compounded GLP-1 marketing⁵
• •FDA reminded the public that compounded drugs are not FDA-approved and are not the same as generic drugs⁵

There are narrow scenarios where compounded tirzepatide may still have a legitimate use case — typically involving a patient-specific need (like an allergy to an inactive ingredient in the branded product), ordered through a licensed prescriber and filled by a reputable 503A pharmacy. This is categorically different from mass-market telehealth platforms selling compounded tirzepatide as a routine alternative to Zepbound.

How We Verified This Page

This is a YMYL (Your Money or Your Life) topic. Here’s where our information comes from.

Frequently Asked Questions